BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24911126)

  • 41. [Diagnostic testing in fragile X syndrome].
    Sireteanu A; Rusu C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic checklist to screen for fragile X syndrome in people with mental retardation.
    Maes B; Fryns JP; Ghesquière P; Borghgraef M
    Ment Retard; 2000 Jun; 38(3):207-15. PubMed ID: 10900928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fragile X population carrier screening.
    Metcalfe SA; Archibald AD; Couns G
    Genet Med; 2012 Mar; 14(3):350; author reply 351. PubMed ID: 22391783
    [No Abstract]   [Full Text] [Related]  

  • 44. Prenatal genetic testing.
    Dolan SM
    Pediatr Ann; 2009 Aug; 38(8):426-30. PubMed ID: 19711880
    [No Abstract]   [Full Text] [Related]  

  • 45. [A large-scale diagnostic program for the fragile X syndrome among the mentally handicapped. I. An epidemiologic survey].
    de Vries LB; van den Ouweland AM; Mohkamsing S; Sandkuijl LA; Oostra BA; Niermeijer MF
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1666-71. PubMed ID: 9890806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preventive screening for the fragile X syndrome.
    Turner G; Robinson H; Laing S; Purvis-Smith S
    N Engl J Med; 1986 Sep; 315(10):607-9. PubMed ID: 3736599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fragile X syndrome.
    Hayes EW; Matalon R
    Pediatrics; 2009 Aug; 124(2):790-2. PubMed ID: 19581265
    [No Abstract]   [Full Text] [Related]  

  • 48. Fragile X Syndrome: Scientific Background and Screening Technologies.
    Lyons JI; Kerr GR; Mueller PW
    J Mol Diagn; 2015 Sep; 17(5):463-71. PubMed ID: 26162330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatricians' knowledge of and attitudes toward fragile X syndrome screening.
    Kemper AR; Bailey DB
    Acad Pediatr; 2009; 9(2):114-7. PubMed ID: 19329102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strategies and logistical requirements for efficient testing in genetic disease.
    Jackson-Cook C; Pandya A
    Clin Lab Med; 1995 Dec; 15(4):839-57. PubMed ID: 8838226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for fragile X syndrome among Brazilian mentally retarded male patients using PCR from buccal cell DNA.
    Christofolini DM; Lipay MV; Ramos MA; Brunoni D; Melaragno MI
    Genet Mol Res; 2006 Jul; 5(3):448-53. PubMed ID: 17117359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of X chromosome aneuploidy using Southern blot analysis during routine population-based screening for fragile X syndrome.
    Adir V; Shahak E; Dar H; Borochowitz ZU
    Genet Test; 2003; 7(4):345-6. PubMed ID: 15000814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole Genome Screening for Sick Newborns: Equity Now.
    Terry SF
    Genet Test Mol Biomarkers; 2021 Oct; 25(10):625-626. PubMed ID: 34672774
    [No Abstract]   [Full Text] [Related]  

  • 55. [Molecular diagnosis of fragile X syndrome].
    Ben Jemaa L; Khemir S; Maazoul F; Richard L; Beldjord C; Chaabouni M; Chaabouni H
    Tunis Med; 2008 Nov; 86(11):973-7. PubMed ID: 19213487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Assessment of chromosome and gene analysis for the diagnosis of the fragile X syndrome in Japan--estimated prevalence rate in various facilities].
    Horiguchi T; Kaga M; Inagaki M
    No To Hattatsu; 2003 Jul; 35(4):297-303. PubMed ID: 12875205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for fragile X syndrome.
    Murray J; Cuckle H; Taylor G; Hewison J
    Health Technol Assess; 1997; 1(4):i-iv, 1-71. PubMed ID: 9414543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Baby genome screening: paving the way to genetic discrimination?
    Seidel MG
    BMJ; 2017 Jul; 358():j3294. PubMed ID: 28729238
    [No Abstract]   [Full Text] [Related]  

  • 59. Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study.
    Bailey DB; Lewis MA; Harris SL; Grant T; Bann C; Bishop E; Roche M; Guarda S; Barnum L; Powell C; Therrell BL
    J Genet Couns; 2013 Feb; 22(1):108-17. PubMed ID: 22736213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A fragile newborn.
    Osier E; Stewart KC; Williams J
    Pediatr Dermatol; 2020 Jul; 37(4):e35-e36. PubMed ID: 32706463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.